SlowBull
The Business Brief MONDAY, 31 AUGUST 2026
← All stories
Markets

H.C. Wainwright reiterates Gain Therapeutics stock rating at buy

1 source ·2 articles ·2h ago Gain Therapeutics

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com News ·2h ago

H.C. Wainwright reiterates CRISPR Therapeutics stock rating at buy

Investing.com News ·2h ago

H.C. Wainwright reiterates Gain Therapeutics stock rating at buy